Yutrepia

Active Ingredient(s): Treprostinil Sodium
FDA Approved: * May 23, 2025
Pharm Company: * LIQUIDIA TECH
Category: Blood Pressure

Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation, is a vasodilator that is used for the treatment of pulmonary arterial hypertension.[1] Treprostinil is a synthetic analog of prostacyclin (PGI2). Treprostinil was approved for use in the United States in May 2002.[2] The drug can be given in various forms: IV, subcutaneous injection, oral inhalation, as well as oral extended-release tablets. The subc... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Yutrepia 26.5 ug/1 Respiratory (Inhalation) Capsule
NDC: 72964-011
Labeler:
Liquidia Technologies, Inc.
Yutrepia 53 ug/1 Respiratory (Inhalation) Capsule
NDC: 72964-012
Labeler:
Liquidia Technologies, Inc.
Yutrepia 79.5 ug/1 Respiratory (Inhalation) Capsule
NDC: 72964-013
Labeler:
Liquidia Technologies, Inc.
Yutrepia 106 ug/1 Respiratory (Inhalation) Capsule
NDC: 72964-014
Labeler:
Liquidia Technologies, Inc.

Related Brands

Drugs with the same active ingredients